RO60, also known as SSA Ro, is an RNA-binding protein that plays a role in the processing and stability of non-coding RNAs. In autoimmune disease lupus, formerly known as systemic lupus erythematosus (SLE), the immune system attacks components of body cells. Autoantibodies produced by the immune system in lupus patients often target proteins like RO60 which become a target of autoantibodies known as anti-Ro/SSA antibodies. The immune complexes formed by these autoantibodies can stimulate antigen specific T cells. Therefore, the connection between RO60 protein and lupus is tied to autoantibo
RO60, also known as SSA Ro, is an RNA-binding protein that plays a role in the processing and stability of non-coding RNAs. In autoimmune disease lupus, formerly known as systemic lupus erythematosus (SLE), the immune system attacks components of body cells. Autoantibodies produced by the immune system in lupus patients often target proteins like RO60 which become a target of autoantibodies known as anti-Ro/SSA antibodies. The immune complexes formed by these autoantibodies can stimulate antigen specific T cells. Therefore, the connection between RO60 protein and lupus is tied to autoantibodies that target specific proteins in the body, playing a significant role in the autoimmune response observed in lupus and can lead potentially to the activation of antigen-specific T cells.
The PepTivator Peptide Pools have been specially developed for efficient in vitro stimulation of antigen-specific CD4+ and CD8+ T cells, as peptides of 15 amino acid length with 11 amino acid overlap represent the optimized solution for stimulating both CD4+ and CD8+ T cells in various applications. Stimulation of T cells with PepTivator Peptide Pools causes the secretion of effector cytokines and upregulation of activation markers, which then allows the detection or isolation of antigen-specific T cells. Quantitative, phenotypical, or functional analysis of antigen-specific T cell immunity can provide important information on the natural course of immune responses in healthy or immunocompromised individuals.